Transcriptogen Ltd
08461104
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2025
total exemption full
Next accounts due
30/09/2027
Confirmation statement
Last: 05/04/2026
Due 19/04/2027
Industry
Officers
director · Since 25/03/2013
PROFESSOR OF DRUG DISCOVERY
BRITISH · UNITED KINGDOM · Age 71
Also on 5 other boards
director · Since 29/05/2013
BIOCHEMIST
BRITISH · UNITED KINGDOM · Age 72
Also on 2 other boards
director · Since 01/01/2017
DIRECTOR
BRITISH · ENGLAND · Age 71
Also on 6 other boards
Persons with Significant Control
Former PSCs
Dr Savvas Ioannou Neophytou
Ceased 28/02/2020
CompanyRankvs 897+ SIC 72110 peers64
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
£204
Balance sheet strength
Cash
£83k
Cash in the bank
Net Current Assets
£82k
Working capital
Current Assets
£84k
Current Liabilities
£2k
Debtors
£725
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2025 | 50.72 |
| 2025 | 50.72 |
| 2024 | 7.16 |
| 2023 | 8.07 |
| 2022 | 91.53 |
| 2021 | 117.28 |
| 2020 | 91.76 |
| 2019 | 0.54 |
| 2018 | 5.94 |
Derived from filed accounts. Not audited figures.